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Retinal microvasculature and 
cerebral small vessel disease in the 
Lothian Birth Cohort 1936 and Mild 
stroke study
sarah McGrory1,2, Lucia Ballerini  1, Fergus N. Doubal1, Julie staals3,4, Mike Allerhand2,5, 
Maria del C. Valdes-Hernandez1, Xin Wang1, Tom MacGillivray  1, Alex S. F. Doney6, 
Baljean Dhillon  1, John M. starr5,7, Mark E. Bastin5,8, Emanuele trucco  9, Ian J. Deary2,5 & 
Joanna M. Wardlaw  5,8,10
Research has suggested that the retinal vasculature may act as a surrogate marker for diseased cerebral 
vessels. Retinal vascular parameters were measured using Vessel Assessment and Measurement 
Platform for Images of the Retina (VAMPIRE) software in two cohorts: (i) community-dwelling older 
subjects of the Lothian Birth Cohort 1936 (n = 603); and (ii) patients with recent minor ischaemic 
stroke of the Mild Stroke Study (n = 155). Imaging markers of small vessel disease (SVD) (white matter 
hyperintensities [WMH] on structural MRI, visual scores and volume; perivascular spaces; lacunes and 
microbleeds), and vascular risk measures were assessed in both cohorts. We assessed associations 
between retinal and brain measurements using structural equation modelling and regression analysis. 
In the Lothian Birth Cohort 1936 arteriolar fractal dimension accounted for 4% of the variance in 
WMH load. In the Mild Stroke Study lower arteriolar fractal dimension was associated with deep WMH 
scores (odds ratio [OR] 0.53; 95% CI, 0.32–0.87). No other retinal measure was associated with SVD. 
Reduced fractal dimension, a measure of vascular complexity, is related to SVD imaging features in 
older people. The results provide some support for the use of the retinal vasculature in the study of brain 
microvascular disease.
Presently, the pathogenesis of cerebral small vessel disease (SVD) in humans is not completely understood, in part 
due to the difficulty in imaging in vivo the cerebral microvasculature. SVD is a syndrome of cognitive, clinical, 
neuroimaging and neuropathological findings arising from disease affecting the perforating cerebral arterioles, 
capillaries and venules and the resulting damage in the cerebral white and deep grey matter1. Due to the anatom-
ical and physiological similarity of the cerebral and retinal vessels2, and the ease with which the retinal microvas-
culature can be imaged, there has been considerable interest in determining whether pathologic changes in the 
retinal vessels may parallel changes in the cerebral small vessels2.
There is strong evidence that retinal vascular features are associated with stroke3,4, SVD stroke subtype5–10, and 
presence and progression of features of SVD11–15. However, previous analyses have focused largely on individual 
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retinovascular signs and individual SVD markers, rather than considering retinovascular abnormalities or SVD 
features as a whole12,13,16.
We aimed to assess an array of retinal measurements in an effort to identify those most closely related to 
individual and total SVD burden independently of any co-association with common vascular risk factors 
(VRFs). We hypothesised that associations between retinovascular changes and SVD lesions would be partly 
explained by, but remain independent of, VRFs. We used quantitative retinal measurements, qualitative (visual 
ratings) and quantitative indicators of white matter hyperintensities (WMH) (WMH% volume) and SVD bur-
den, medical-history-derived- and measured vascular risk variables, in two cohorts: the Lothian Birth Cohort 
(LBC1936), and the Mild Stroke Study (MSS). The LBC1936 represents a narrow age range at the ‘healthy’ end 
of the SVD spectrum. The MSS represents a wider age range with clinically evident brain vascular disease and a 
higher burden of SVD and VRFs. Analysis of these separate but complementary population samples allows us 
to examine the relationship between retinovascular and SVD features at different points on the SVD spectrum.
Results
LBC1936. In the LBC1936, 866 participants (448, 52% male) of mean age 72.5 years (SD 0.7) attended for 
clinical assessment; 681 participants completed brain imaging and provided WMH and SVD ratings and vol-
umes. The 603 participants with retinal imaging measurements available for both right and left eyes provided data 
as the analytic sample for the present study (Table 1). Of the 603 (303, 50% male), 270 (45%) had hypertension, 58 
(10%) had diabetes (Table 1), and 31% had moderate or severe periventricular WMH scores with 19% moderate 
or severe deep WMH scores (Table 2). Of the 603, 33 participants reported having had a stroke (of whom 11 also 
had evidence of stroke on imaging), and an additional 51 had imaging-only evidence of a stroke lesion, giving a 
total with any stroke of 84 (14%).
Prior to structural equation modelling (SEM), initial analyses in the LBC1936 used regression with 16 retinal 
variables as exposures and 11 brain variables as outcomes. The results of these multiple linear regression, adjusted 
for age and sex, are presented in Table 3. Three of the 176 associations survived adjustment and false discovery 
rate (FDR) correction. Decreased arteriolar fractal dimension (decreased branching complexity) was associated 
with greater WMH volume percentage in both brain tissue volume (BTV) (β = −0.203, p < 0.001), and intrac-
ranial volume (ICV) (β = −0.203, p < 0.001), and higher Fazekas scores in periventricular regions (β = −0.157, 
p < 0.001). The following nominally significant age- and sex- adjusted associations attenuated to non-significance 
with FDR correction: arteriolar fractal dimension with Fazekas scores in deep white matter regions; venular 
fractal dimension with WMH % BTV and ICV; venular tortuosity with BTV mm3, Fazekas score in deep white 
matter, perivascular spaces (PVS) score and SVD score; and arteriolar branching coefficient with deep and super-
ficial atrophy ratings, arteriolar asymmetry factor with deep atrophy ratings, and arteriolar length-diameter ratio 
with ICV (mm3).
Variable Lothian Birth Cohort 1936 Mild Stroke Study
Sample no. 603 155
Age, mean (SD) 72.5 (0.7) 66.9 (11.4)
Sex
  Female 300 (50) 47 (32)
  Male 303 (50) 98 (68)
Vascular risk factors
Hypertension
  No 333 (55) 58 (40)
  Yes 270 (45) 87 (60)
Diabetes
  No 545 (90) 126 (87)
  Yes 58 (10) 19 (13)
Hypercholesterolemia
  No 375 (62) 88 (62)
  Yes 228 (38) 55 (38)
Cholesterol, mmol/L 5.24 (1.16) 4.99 (1.25)
HbA1c Blood Glucose, mmol/L
5.72 (0.60) 6.24 (3.11)
Smoker
  Ex, or never 557 (92) 61 (42)
  Yes 46 (8) 84 (58)
Diastolic BP, mm Hg 78.22 (9.59) 85.32 (13.47)
Systolic BP, mm Hg 148.48 (18.99) 150.32 (28.26)
Table 1. Characteristics of the Lothian Birth Cohort 1936 and the Mild Stroke Study: M (SD) for Continuous 
Variables and N (%) for Categorical Variables. Note. BP = blood pressure; HbA1c = haemoglobin A1c; 
WMH = white matter hyperintensities.
3Scientific RepoRts |          (2019) 9:6320  | https://doi.org/10.1038/s41598-019-42534-x
www.nature.com/scientificreportswww.nature.com/scientificreports/
The above analyses were re-run after excluding LBC1936 participants with history of stroke (n = 84) 
(Supplementary Table S1). Two additional associations survived adjustment and FDR correction in this sensi-
tivity analysis; decreased venular fractal dimension was associated with increased WMH % in BTV (β = −0.175, 
p = 0.03) and ICV (β = −0.178, p = 0.03). The three other previously-significant associations with arteriolar frac-
tal dimension remained significant.
Variable Lothian Birth Cohort 1936 Mild Stroke Study
Brain measurements, mean (SD)
WMH % in BTV 1.00 (1.11) 1.69 (2.05)
WMH % in ICV 0.77 (0.85) 1.33 (1.62)
Ratings
Fazekas score (periventricular)
  0 17 (4) 6 (4)
  1 310 (66) 69 (48)
  2 116 (24) 41 (28)
  3 28 (6) 29 (20)
Fazekas score (deep white matter overall)
  0 77 (16) 22 (15)
  1 306 (65) 79 (54)
  2 77 (16) 21 (15)
  3 11 (2) 23 (16)
PVS (basal ganglia) Range: 0–3 Range: 0–1*
  0 1 (0) 87 (60)
  1 279 (60) 57 (40)
  2 173 (37) —
  3 14 (3) —
Microbleeds
  0 420 (90) 122 (85)
  1 47 (10) 22 (15)
SVD score
  0 220 (47) 69 (48)
  1 164 (35) 27 (19)
  2 68 (15) 29 (20)
  3 15 (3) 14 (10)
  4 0 5 (3)
Retinal measurements, mean (SD)
CRAE 31.19 (2.19) 30.93 (2.80)
CRVE 42.12 (3.16) 43.67 (3.59)
BSTDa 2.20 (0.64) 2.10 (0.65)
BSTDv 3.94 (0.86) 4.01 (0.90)
FDa 1.59 (0.05) 1.59 (0.05)
FDv 1.57 (0.04) 1.58 (0.04)
TORTa (log transformed) −9.98 (0.96) −10.01 (0.88)
TORTv (log transformed) −9.91 (0.69) −9.76 (0.73)
BCa 2.09 (0.22) 2.14 (0.30)
BCv 1.98 (0.24) 1.98 (0.33)
LDRa 19.37 (5.04) 21.81 (11.21)
LDRv 18.91 (4.96) 19.55 (5.36)
AFa 0.92 (0.04) 0.90 (0.05)
AFv 0.90 (0.05) 0.88 (0.06)
Table 2. Descriptive Statistics for Brain and retinal imaging-derived measurements in the Lothian Birth 
Cohort 1936 and the Mild Stroke Study: M (SD) for Continuous Variables and N (%) for Categorical 
Variables. Note. BTV = brain tissue volume; ICV = intracranial volume; PVS = perivascular spaces (in basal 
ganglia); *0: none-mild; 1: moderate-severe. SVD = small vessel disease; CRAE = central retinal arteriolar 
equivalent; CRVE = central retinal vein equivalent; BSTDa = standard deviation of arteriolar widths in Zone B; 
BSTDv = standard deviation of venular widths in Zone B; FDa = arteriolar fractal dimension; FDv = venular 
fractal dimension; TORTa = arteriolar tortuosity; TORTv = venular tortuosity; BCa = arteriolar branching 
coefficient; BCv = venular branching coefficient; LDRa = arteriolar length diameter ratio; LDRv = venular 
length diameter ratio; AFa = arteriolar asymmetry factor; AFv = venular asymmetry factor.
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Measurement models in SEM to derive the latent traits of VRF, ‘WMH load’, ‘SVD burden’ and retinal 
‘calibre-complexity’ in the LBC1936 sample (Supplementary Figs S1–S3) indicate that almost all measured vari-
ables contributed significantly to their hypothesised latent variable (with parameter weights with p < 0.05). The 
exceptions were: smoking (p = 0.34), as found in the VRF latent variable derived previously in the LBC193617; and 
microbleeds in the SVD latent trait (p = 0.29). Nonetheless, these variables were included in the VRF and SVD 
latent traits. All models had acceptable fit to the data (Supplementary Figs S1–S3).
SEMs used to test hypothesized relationships among latent variables of ‘calibre-complexity’ and ‘WMH 
load’ and ‘SVD burden’ in LBC1936 are shown in Fig. 1. In addition to the contributions of age, sex and VRFs, 
‘calibre-complexity’ was significantly associated with the latent traits of WMH load (standardised parameter 
weight −0.181, p < 0.001) (Fig. 1a) and SVD burden (standardised parameter weight −0.141, p = 0.021) (Fig. 1b). 
This retinal construct of vessel calibre and branching complexity accounted for approximately 3.3% and 2.0% of 
the variance in WMH load and SVD burden, respectively. However, the association between ‘calibre-complexity’ 
and SVD burden attenuated to non-significance once corrected for multiple comparisons (p = 0.054).
SEMs used to test hypothesized relationships among individual retinal variables (identified from age- and sex- 
adjusted regression models, see Table 3), and latent constructs of WMH load and SVD burden in LBC1936 are 
shown in Fig. 2. In addition to the contributions of age, sex and VRFs, reduced arteriolar fractal dimension was 
significantly associated with the latent traits of WMH load (standardised parameter weight −0.211, p < 0.001) 
(Fig. 2A) and SVD burden (standardised parameter weight −0.168, p = 0.002) (Fig. 2B), accounting for approx-
imately 4.4% and 2.8% of the variance in WMH and SVD respectively. These associations survived FDR correc-
tion. The VRF latent trait was not significantly associated with fractal dimension or either SVD or WMH latent 
trait (Fig. 2).
We tested additional SEMs—to test for co-association of retinal and SVD indicators with VRFs—of the three 
relationships between retinal variables and individually-measured brain imaging variables that had surviving 
age-, sex-, and FDR adjustment (Table 3). The results are shown in Supplementary Fig. S13. All retinal-brain 
associations remained significant and survived FDR correction.
MSS. Among those participants of the MSS cohort with retinal images of both eyes available for analysis 
(n = 155; 98, 68% male), of mean age 66.9 years (SD 11.4), 87 (60%) had hypertension, 19 (13%) had diabetes 
(Table 1). Seventy (48%) had moderate or severe periventricular WMH scores, and 44 (30%) with moderate or 
severe deep WMH scores (Table 2).
In age- and sex-adjusted linear regression models, only one association remained significant following cor-
rection for FDR; reduced arteriolar fractal dimension was significantly associated with higher WMH scores in 
deep white matter regions (β = −0.327, p < 0.001). The following 12 nominally significant age- and sex- adjusted 
CRAE CRVE BSTDa BSTDv FDa FDv TORTa TORTv BCa BCv AFa AFv LDRa LDRv





β β β β β β β β β β β β β β β β
WMH % in BTV −0.091 −0.076 0.050 0.014 −0.203*** −0.140a −0.027 0.084 0.030 −0.019 0.008 0.031 0.069 0.018 0.025 0.025
BTV mm3 −0.053 0.043 −0.089 −0.036 0.020 −0.017 −0.035 −0.113a 0.029 −0.063 −0.070 −0.042 −0.031 −0.007 0.007 0.068
WMH % in ICV −0.091 −0.076 0.049 0.016 −0.203*** −0.143a −0.027 0.082 0.031 −0.019 0.008 0.028 0.073 0.021 0.025 0.026
ICV mm3 −0.065 0.071 −0.099 −0.084 0.027 0.037 −0.039 −0.083 0.008 −0.101 −0.102 0.003 −0.131a −0.082 0.007 0.075
Fazekas 
Periventricular −0.054 0.013 0.083 0.022 −0.157*** −0.080 0.000 0.083 −0.034 0.043 0.000 0.017 0.008 −0.003 0.012 −0.011
Fazekas Deep −0.016 −0.010 0.054 0.056 −0.118a −0.084 0.008 0.113a −0.010 0.023 0.014 −0.005 0.060 0.044 0.022 0.059
Atrophy Deep −0.035 −0.007 0.024 −0.011 −0.076 0.021 0.021 0.073 0.113a 0.075 −0.100a −0.032 −0.038 −0.058 0.042 −0.019
Atrophy 
Superficial −0.017 −0.007 0.044 −0.041 −0.071 0.026 0.011 0.046 0.112
a 0.076 −0.082 −0.001 −0.062 −0.072 −0.024 −0.014
PVS −0.043 0.028 −0.014 −0.044 0.041 0.080 0.010 0.146a −0.005 −0.016 0.047 0.038 −0.014 0.041 0.002 −0.029
Microbleeds −0.020 0.003 −0.052 0.000 0.000 0.016 0.028 −0.018 −0.062 −0.024 0.025 0.032 0.019 −0.067 −0.039 −0.048
SVD score −0.059 0.009 −0.005 −0.009 −0.051 0.025 0.007 0.141a −0.029 0.018 0.040 0.024 0.033 0.001 0.037 −0.005
Table 3. Age- and sex- adjusted associations between retinal and brain imaging-derived measurements in 
Lothian Birth Cohort 1936. Note. Model adjusted for age and sex. WMH = white matter hyperintensities; 
BTV = brain tissue volume; ICV = intracranial volume; PVS = basal ganglia perivascular spaces; 
SVD = small vessel disease; CRAE = central retinal artery equivalent; CRVE = central vein retinal equivalent; 
BSTDa = standard deviation of arteriolar widths in Zone B; BSTDv = standard deviation of venular widths in 
Zone B; FDa = fractal dimension arteriolar; FDv = fractal dimension venular; TORTa = arteriolar tortuosity; 
TORTv = venular tortuosity; BCa = arteriolar branching coefficient; BCv = venular branching coefficient; 
AFa = arteriolar asymmetry factor; AFv = venular asymmetry factor; LDRa = arteriolar length diameter ratio; 
LRDv = venular length diameter ratio; Gradient a = arteriolar width gradient; Gradient v = venular width 
gradient; PC = principal component; Bolded values are statistically significant. WML % volumes and tortuosity 
log transformed. β, Standardised regression coefficients. *p < 0.05; **p < 0.01; ***p < 0.001; all p-values 
corrected for False Discovery Rate. aValue was statistically significant at p < 0.05 before FDR correction.
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associations attenuated to non-significance after applying FDR correction: central retinal artery equivalent 
(CRAE) with WMH % BTV and ICV, variation in arteriolar widths with WMH % BTV and ICV; variation in 
venular widths with WMH % in BTV and ICV and Fazekas scores in deep white matter; arteriolar fractal dimen-
sion with WMH % in BTV, ICV, Fazekas scores in periventricular region, and SVD score; and venular branching 
coefficient and Fazekas score in deep white matter region (Table 4).
We conducted further multivariable ordinal regression analysis on the surviving association between arteri-
olar fractal dimension and deep white matter Fazekas score, introducing the VRF component as an additional 
covariate to age and sex (Table 5). Lower arteriolar fractal dimension remained significantly associated with deep 
WMH Fazekas scores, with OR (95% CI) of 0.53 (0.32–0.87).
Discussion
To our knowledge, the current study is the first that uses SEM to investigate the relationship between retinal 
microvascular and brain imaging markers of SVD. Whereas our retinal data reduction approach found most 
retinal measurements to be largely independent, i.e. not indicators of the same latent trait, we did find four retinal 
variables with considerable shared variance reflecting aspects of geometry, namely vessel width and complexity. 
This combined vessel calibre-complexity latent trait was related to SVD burden and WMH load in the LBC1936. 
Examining retinal variables individually in the LBC1936, we found participants with decreased arteriolar fractal 
dimension, suggesting of a loss of branching complexity, were more likely to have greater cerebral SVD pathology, 
independent of VRF. Sparser arteriolar microvasculature was also associated with more WMH. All effect sizes 
were small. The relatively larger effect sizes of the results using individual retinal variables suggest that the rela-
tionship between ‘calibre-complexity’ and SVD burden is largely driven by the effect of reduced arteriolar fractal 
dimension. Findings were generally consistent in the MSS participants despite the wider age range and increased 
burden of vascular disease; MSS participants with sparser arteriolar fractal dimension were more likely to have 
more WMH in deep white matter. The small non-significant associations between VRF and WMH, accounting 
for less than 2% of the variance in WMH, are in line with those of Wardlaw et al. (2014) in reporting that VRFs 
Figure 1. Structural models for retinal latent traits predicting WMH/SVD burden in the LBC1936. (a) Model 
of retinal calibre-complexity predicting WMH Load; (b) Model of retinal calibre-complexity predicting SVD 
burden; Standardised regression coefficients (parameter weights) are shown adjacent to each path. P-values 
corrected for False Discovery Rate. The rectangles to the left are the covariates in the model. Each of the 
covariates was examined for their contribution to VRF, ‘Calibre-complexity’ and WMH Load/SVD Burden, 
and only significant (p < 0.05) contributions are shown. VRF = vascular risk factor; WMH = white matter 
hyperintensities; SVD = small vessel disease. Dashed lines represent non-significant associations; dotted line 
represents nominally significant association.
Figure 2. Structural models for retinal fractal dimension measurements predicting WMH/SVD burden 
in the LBC1936. (A) Model of FDa predicting WMH Load; (B) Model of FDa predicting SVD burden; 
Standardised regression coefficients (parameter weights) are shown adjacent to each path. P-values corrected 
for False Discovery Rate. The rectangles to the left are the covariates in the model. Each of the covariates was 
examined for their contribution to VRF, FDa and WMH Load/SVD Burden, and only significant (p < 0.05) 
contributions are shown. FDa = arteriolar fractal dimension; VRF = vascular risk factor; WMH = white matter 
hyperintensities; SVD = small vessel disease. Dashed lines represent non-significant associations.
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only account for a small proportion of the variance in WMH17. Our findings add further weight to the concept 
that easy to measure, common VRFs explain only a small proportion of both variance in retinal vascular and 
brain SVD features, leaving a large proportion unexplained.
These findings add further support to the hypothesis that retinal fractal dimension, as a global summary 
measure of the state or health of the retinal vasculature, might have a significant association with the changes 
taking place in cerebral small vessels. A loss of branching complexity in regulatory systems of other organs of the 
body is thought to occur as they become less complex with age18. In line with our results, Hilal et al. (2014) found 
those with reduced arteriolar fractal dimension were more likely to have cerebral microbleeds12. Reduced fractal 
dimension has also been found in Alzheimer’s disease19–21. Decreased branching complexity of the arteriolar and 
venular networks combined in lacunar stroke, a manifestation of SVD, has previously been reported in the MSS 
cohort6.
A large number of association tests were conducted, and several significant associations became 
non-significant once corrected for multiple testing. Whereas the amount of associations conducted increases the 
likelihood of type-1 errors, it is also possible that our robust correction for multiple testing is rejecting modest but 
true associations; larger sample sizes are needed to confirm them22. We interpret all unadjusted significant asso-
ciations cautiously as they may reflect spurious associations. However, they could provide directions for future 
research. Without adjustment, some additional retinal measurements, including venular tortuosity and arteriolar 
measures of branching geometry, appeared relevant for some markers of SVD.
A limitation of the study is its cross-sectional design. Longitudinal studies examining retinal changes and 
progression of SVD and WMH would be valuable. The smaller sample size of the MSS cohort did not allow for 
CRAE CRVE BSTDa BSTDv FDa FDv TORT a TORTv BCa BCv AFa AFv LDRa LDRv





β β β β β β β β β β β β β β β β
WMH in BTV −0.269a −0.035 −0.270a −0.392a −0.365a −0.094 −0.055 −0.252 −0.044 −0.134 −0.026 −0.021 −0.062 −0.036 −0.199 −0.036
BTV mm3 0.040 −0.067 0.226 0.147 −0.064 −0.007 −0.074 0.209 0.242 −0.115 0.186 −0.017 0.187 −0.137 0.037 −0.080
WMH in ICV −0.266a −0.036 −0.257a −0.383a −0.370a −0.091 −0.049 −0.247 −0.044 −0.136 −0.018 −0.028 −0.063 −0.036 −0.202 −0.033
ICV mm3 0.004 −0.069 0.006 0.015 0.046 −0.029 −0.175 0.129 0.257 −0.082 0.084 0.129 0.216 −0.118 0.113 −0.121
Fazekas Peri −0.177 −0.046 −0.105 −0.133 −0.308a −0.085 −0.039 0.030 −0.123 −0.193 0.021 −0.018 −0.118 −0.017 −0.009 −0.054
Fazekas Deep −0.187a −0.025 −0.026 −0.115 −0.327*** 0.026 0.026 0.161 −0.087 −0.216a 0.169 −0.033 −0.122 −0.124 0.027 −0.050
Atrophy Deep −0.095 −0.050 −0.194 −0.260a −0.157 0.035 −0.022 −0.016 −0.144 0.092 0.027 0.070 −0.147 0.128 0.032 −0.011
Atrophy Superficial −0.168 −0.039 −0.170 −0.101 −0.118 −0.069 −0.070 −0.085 −0.026 0.038 0.029 −0.029 −0.046 0.085 0.124 0.011
PVS −0.152 0.043 −0.053 −0.097 −0.158 0.007 0.020 0.035 0.120 −0.032 −0.025 −0.018 0.021 −0.118 −0.050 −0.141
Microbleeds −0.146 0.096 −0.033 −0.073 −0.142 0.024 −0.120 0.071 −0.047 −0.125 0.087 −0.113 −0.090 −0.171 0.123 −0.170
SVD score −0.158 0.016 −0.024 −0.100 −0.274a 0.004 −0.029 0.095 0.085 −0.145 0.065 −0.034 0.016 −0.145 0.042 −0.105
Table 4. Age- and sex- adjusted associations between retinal and brain imaging-derived measurements in 
MSS. Note. Model adjusted for age and sex. WMH = white matter hyperintensities; BTV = brain tissue volume; 
ICV = intracranial volume; PVS = basal ganglia perivascular spaces; SVD = small vessel disease; CRAE = central 
retinal artery equivalent; CRVE = central vein retinal equivalent; BSTDa = standard deviation of arteriolar 
widths in Zone B; BSTDv = standard deviation of venular widths in Zone B; FDa = fractal dimension arteriolar; 
FDv = fractal dimension venular; TORTa = arteriolar tortuosity; TORTv = venular tortuosity; BCa = arteriolar 
branching coefficient; BCv = venular branching coefficient; AFa = arteriolar asymmetry factor; AFv = venular 
asymmetry factor; LDRa = length diameter arteriolar; LDRv = length diameter ration venular; PC = principal 
component; Bolded values are statistically significant. WML % volumes and tortuosity log transformed. β, 
Standardised regression coefficients. *p < 0.05; **p < 0.01; ***p < 0.001; All p-values corrected for False Discovery 
Rate. aValue was statistically significant at p < 0.05 before FDR correction.
Fazekas Deep†
OR (95% CI) p
Male 1.23 (0.49; 3.42) 0.596
Age 2.30 (1.45; 3.65) <0.000
VRF 0.85 (0.54; 1.33) 0.474
FDa 0.53 (0.32; 0.87) 0.012
Table 5. Multivariate regression analysis of brain imaging-derived measurements of SVD in the Mild Stroke 
Study. All variables in column 1 were entered simultaneously as independent variables in the models. Note. 
Multivariate analysis with correction for all variables in the table. OR = odds ratio; CI = confidence interval; 
FDa = arteriolar fractal dimension; SVD = small vessel disease. †Ordinal regression with Fazekas score (0–3) as 
dependent variable. Continuous predictors were converted to z-scores.
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consistent statistical methods across cohorts. Furthermore, despite the use of a validated semi-automated soft-
ware application; VAMPIRE (Vessel Assessment and Measurement Platform for Images of the Retina, version 
3.1, Universities of Edinburgh and Dundee), a degree of subjective human interaction introduces potential for 
intra-grader variability. Sources of variability of retinal measurements from fundus images have been discussed, 
among others, in Trucco et al.23. We also acknowledge our retinal variables data reduction approach represents 
a first step towards a composite measure of abnormality and subsequent choice of variables is not definitive. 
Other studies may reach different conclusions based on their data. The participants’ age may have reduced the 
strength of the associations between VRF, WMH and retinal measurements. The relationship between WMH and 
hypertension appears stronger in middle age24. A systematic review of associations between retinal microvascular 
changes, dementia and brain imaging features reported stronger findings in middle-aged populations25, in line 
with the age-related attenuation of associations between VRFs, hypertension and cerebrovascular disease and 
retinopathy26,27. Due to the low prevalence in our samples, mircobleeds were included regardless of their location. 
It is possible that including lobar microbleeds might ‘contaminate’ this predominantly subcortical SVD score 
with microbleeds related to cerebral amyloid angiopathy. Future work in other cohorts with greater prevalence 
allowing for separate analysis by location, lobar versus deep, should seek to determine if microbleeds may play a 
larger role.
The strengths of the current study include the use of two distinct, yet complementary, well-characterised 
cohorts. This provides a more comprehensive account of the relationship between the retinal and cerebral micro-
vasculature in different populations, representing different points on the SVD continuum. Furthermore, the 
LBC1936 as a narrow-age cohort, reduces the troublesome problem where chronological age confounds the influ-
ence of other variables. All LBC1936 and MSS participants were imaged using the same retinal camera and MRI 
scanner, at the same time period, according to the same brain and retinal image analysis methods. This included 
the use of standardised retinal and cerebral examinations and the use of both quantitative and qualitative WMH 
measures with the careful exclusion of infarcts from WMH volume. Additional strengths include the use of robust 
statistics. The sample size in the LBC1936 allowed us to account for measurement error by using SEM to derive 
error-free latent contracts for VRF, WMH and SVD.
In summary, we provide some evidence to support concomitant retinal and cerebral microvasculature 
changes, with a small but significant association between reduced retinal arteriolar branching complexity and 
SVD pathology, known to represent a significant risk factor for dementia and stroke28. That sparser vasculature 
is associated with WMH and SVD burden, suggests that the retinal microvasculature can exhibit corresponding 
microvascular signs of altered vascular competence leading to tissue damage in the brain. These data extend the 
research potential of retinal imaging beyond the eye in studying neurovascular disease1 and paves the way for 
further studies into mechanism of dementia and stroke and possibly to refine the prognostic potential of detailed 
retinal microvascular analysis, although we again note that the associations are small. The added value of embed-
ding retinal image analytics in cross-linked health datasets to study SVD is yet to be determined; this requires 
intra-individual change detection in stratified prospective cohorts to be tracked. As a cross-sectional study, we 
can only determine associations not causation, nor the progression of cerebral SVD. Despite our efforts in judging 
the statistical significance of the results with FDR correction, the associations found in this study need future rep-
lication in independent samples. Careful validation of our findings is required for better characterizing the retinal 
changes accompanying SVD, and in considering whether retinal measures have a place in clinical work such as in 
screening or as outcomes in trials. Further studies are required to elucidate whether changes to retinal properties 
precede pathology or a response to long-term exposure to risk factors.
Methods
Participants. The LBC193629 comprised community-dwelling, mostly healthy older adults, of mean age 
about 70 years when first recruited in older age. All were born in 1936. The data analysed for the present study, 
including digital retinal photographs and structural brain imaging, were obtained at a second wave of testing 
when the participants were approximately 73 years old (N = 866). The recruitment and testing of the LBC1936 
has been described in detail previously29–31.
The Mild Stroke Study (MSS)5 is a prospective study of patients with recent (within 3 months) clinical lacunar 
or mild cortical ischaemic stroke. All patients were assessed by an experienced stroke physician. The recruitment, 
testing and imaging of these patients has been described previously5,11.
Both studies were approved by Lothian Research Ethics (LBC1936: REC 07/MRE00/58; MSS: 2002/8/64). 
The LBC1936 study was also approved by the Scottish Multicentre (MREC/01/0/58) Research Ethics. Written 
informed consent for participation in both studies was obtained from all participants. The research was carried 
out in compliance with the Helsinki Declaration.
Measures. Retinal image acquisition and analysis. In both groups, digital retinal fundus images were cap-
tured using the same non-mydriatic camera at 45° field of view (CRDGi; Canon USA, Lake Success, New York, 
USA). 814 LBC1936 (from Wave 2 of testing) and 190 MSS participants provided retinal images of both eyes. 
Images were centred approximately on the optic disc. For the present analysis, the retinal images were reanalysed 
for retinal vascular characteristics using the same semi-automated software package, VAMPIRE by an experi-
enced operator. VAMPIRE image processing and analysis has been described in detail previously32–34. Briefly, the 
boundaries of the optic disc (OD) and position of the fovea in a retinal image are first detected and the conven-
tional set of OD-centred circular measurement zones established. Zone B is a ring 0.5 to 1 OD diameters away 
from the centre, and Zone C is a ring extending from OD boundary to 2 OD diameters away. Next, the software 
detects the retinal blood vessels present in the image and classifies them as arterioles or venules. The observer, 
when necessary followed a standardised measurement protocol to preform manual interventions to correct 
computer-generated labelling of image features, blind to all prior retinal analysis, brain and VRF data. There were 
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complete retinal measurements from both eyes for 603 LBC1936 and 155 MSS participants. Rejections were due 
to poor quality images, eyelashes causing streaks across the photograph, out-of-focus images, and overexposure 
(in either eye); these occurred in approximately 16% of LBC1936 images, and 8% of MSS images, with an addi-
tional 4% of MSS images excluded due to considerable differences in image resolution (arising from deviations 
from standard operation of the system when imaging).
Sixteen retinal vascular parameters were measured from each image in both cohorts: measures of vessel 
calibre—central retinal artery equivalent (CRAE), central retinal vein equivalent (CRVE), and the variation in 
calibre—the standard deviation of arteriolar and venular widths (BSTDa, BSTDv); the gradient of the width 
of the main arteriolar and venular vessel paths (GRADa, GRADv); measures of branching complexity—arteri-
olar and venular fractal dimension (FDa, FDv); measures of vessel tortuosity—arteriolar and venular tortuos-
ity (TORTa, TORTv); and measures of arteriolar and venular branching geometry—branching coefficient (BCa, 
BCv), length-diameter ratio (LDRa, LDRv) and asymmetry factor (AFa, AFv). A lowercase ‘a’ or ‘v’ following the 
variable name indicates a measurement of arteriolar or venular vessels respectively. See Supplementary Material 
for details on all retinal measurements and how retinal variables were selected for analysis. To reduce the number 
of variables, reduce multicollinearity and increase reliability, the above-mentioned measurements from both eyes 
of each participant were averaged to provide a mean measurement for all variables.
MRI brain image acquisition and processing. LBC1936 and MSS participants (at time of presentation) underwent 
brain MRI on the same 1.5-Tesla GE Signa Horizon HDx clinical scanner (General Electric, Milwaukee, WI) with 
T1-, T2- and T2*- weighted and fluid-attenuated inversion recovery (FLAIR) axial whole-brain imaging. Full 
details of the brain imaging scanning protocol for the LBC1936 and MSS have been described previously11,31. All 
analyses were performed blinded to all other data. The SVD lesions in both studies were assessed qualitatively and 
quantitatively using validated methods according to a precursor to the STRIVE criteria35. WMH were visually 
scored using FLAIR-, T1 and T2-weighted sequences on the Fazekas score36 in both the deep (0–3) and periven-
tricular (0–3) white matter. Appropriate sequences were also rated for the presence of microbleeds (location and 
number), lacunes (location and number), and perivascular spaces (in basal ganglia and centrum semiovale, 0–4 
point score each) according to an established rating protocol37. Brain atrophy was coded using a validated tem-
plate38, with superficial and deep atrophy coded separately.
We combined the visual lesion scores into an ordinal ‘total SVD score’ of 0–4, described previously39. Briefly, 
a scale point was awarded for the presence of (early) confluent deep (2–3) WMH and/or irregular periventricular 
WMH extended into the deep white matter (3); one or more lacunes; one or more microbleeds; and moderate 
to severe grading (2–4) of basal ganglia perivascular spaces. These showed face-validity both as an ordinal score 
and as a latent variable in previous analyses both in the present cohorts and in other studies39,40. All rating was 
performed by a consultant neuroradiologist trained and experienced in SVD features and use of the visual ratings. 
Quality control of images has been described previously17,40.
Quantitative measures of WMH, brain and intracranial volume were obtained using T2*-weighted and FLAIR 
sequences with a validated semi-automated multispectral image processing tool, MCMxxxVI41. This tool was 
used to measure intracranial volume (ICV, soft tissue structures within the cranial cavity including brain, cerebro-
spinal fluid, dural and venous sinuses), brain tissue volume (BTV, intracranial volume excluding the ventricular 
cerebrospinal fluid) and WMH. The structure volumes were measured as absolute values in cubic millimetres 
(BTV mm3, ICV mm3). Quantitative measures of WMH were expressed as percentage of WMH volume in ICV 
(WMH % ICV) and percentage of WMH volume in BTV (WMH % BTV).
Covariates. Age and sex were included as covariates in both the LBC1936 and MSS samples. Measures of vas-
cular risk were included as covariates in both samples. VRFs were assessed in the LBC1936 subjects at age ~73 
years, at the same session as the retinal photography, and a mean (SD) of 9 (5) weeks prior to brain imaging; they 
were assessed on presentation in the MSS, at the same time as brain imaging, and approximately four weeks prior 
to retinal photography. A combination of medical history variables (medically diagnosed hypertension, diabe-
tes, smoking, and hypercholesterolemia), and measured variables (blood pressure [BP], haemoglobin A1c, and 
plasma cholesterol) were used. The average of three sitting BP measurements were used to derive mean systolic 
and mean diastolic BP variables in LBC1936 and one BP reading was used for MSS subjects. The above measures 
were recorded for MSS subjects with the exception of haemoglobin A1c. All measures were performed blinded to 
all other data. Variables were selected based on a set of measures of vascular risk that we had identified contrib-
uted to vascular risk of WMH in previous LBC1936 and MSS analysis17.
Statistical analysis. Age- and sex-adjusted linear regression was used to analyse the association between the 16 
retinal vascular characteristics and the structural brain imaging-derived measurements in both cohorts. To min-
imise the potential for type I errors, p values were adjusted according to the false discovery rate (FDR) method42. 
LBC1936 participants with a history of stroke (n = 84, 14%; based on medical history and/or brain imaging 
appearances) were removed in a sensitivity analysis. Due to the small size and insufficient stroke classification this 
group could not be divided into stroke subtypes. VRFs were tested as possible explanatory variables for any signif-
icant associations between retinal and brain imaging variables, since both retinal vascular abnormalities and SVD 
features are known to be associated with common VRFs such as hypertension, smoking, diabetes, etc.; this was 
examined using SEM in LBC1936, and multivariable regression models in the MSS cohort (which we judged to be 
too small for SEM). See Penke and Deary (2010) for an accessible description of SEM as applied in neuroscience43.
The basic questions in the analyses were whether retinal vessel measures were associated with brain imaging 
measures, and whether these associations were co-associated with VRFs. The LBC1936 is both large in size and 
has multiple measures of brain white matter health and VRFs. Therefore, in testing the questions above, we were 
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able to form multi-variable ‘latent traits’ (unobservable constructs underlying a combination of correlated indi-
vidual measured variables) for retinal features, white matter health, and vascular risk. Results from the regression 
analyses in the LBC1936 were used to motivate the hypothesized relationships subsequently to be tested by SEM.
We showed previously that VRFs, WMH measures and SVD features formed latent variables in the 
LBC193617,40,44. Therefore, we used the same measurement models to derive the latent variables. Vascular risk 
was measured as a single latent factor from eight variables; hypertension, diabetes, hypercholesterolemia, smok-
ing, (treated) systolic and diastolic BP, haemoglobin A1c, and plasma cholesterol, as previously17. The volume of 
WMH as a percentage of ICV, and Fazekas ratings in periventricular and deep white matter were used to derive 
a latent variable of ‘WMH load’ as previously44. ‘SVD burden’ was measured using a single latent factor with five 
indicators, namely, Fazekas ratings for both periventricular and deep regions, lacunes, microbleeds, and basal 
ganglia perivascular spaces, as previously40. This was undertaken to test whether including three additional imag-
ing markers of SVD might increase the ability to find significant associations. A single latent ‘calibre-complexity’ 
factor was derived from four retinal indicators; two measures of vessel width (CRAE, CRVE), and two meas-
ures of branching complexity; arteriolar and venular fractal dimension. The derivation of this latent variable is 
described fully in the Supplementary Material. All models were estimated using R’s lavaan SEM package, version 
0.5–2245.
Models were estimated using the robust (mean and variance adjusted) weighted least squares (WLSMV) 
estimator. WLSMV is robust to non-normality and is appropriate for model estimation with categorical data. 
Standardised regression coefficients (parameter weights, comparable to standardised partial beta weights) were 
computed for each path in the models. Model fit was assessed using cut-off points of >0.06 for the root mean 
square error of approximation (RMSEA), and ≥0.90 for the comparative fit index (CFI) and Tucker-Lewis index 
(TLI). Measurement models for latent traits are shown in Supplementary Figs S1–S3.
We tested the same two questions in the MSS as above for the LBC1936. However, due to the smaller sample 
size, latent variables were not formed in MSS and we did not use SEM to test hypotheses. Instead, multivariable 
regression models were applied in the MSS to test for associations between retinal and brain imaging-derived 
measurements, and the controls were applied for age, sex, and VRFs. To reduce the number of vascular risk 
parameters and the likelihood of type I errors, principal components analysis (PCA) was applied to the eight 
measured VRF variables in MSS. The first unrotated principal component accounted for a substantial percentage 
of the overall variance in VRF variables (26%), with loadings ranging between 0.18 and 0.77, and was used to gen-
erate a general VRF score. To validate the use of a principal component score, factor scores for VRFs were derived 
using the same PCA method in the LBC1936 sample. The correlation between the VRF principal component 
score from PCA analysis and the VRF latent trait obtained using SEM in the LBC1936 was very strong (r = 0.89). 
Multivariable ordinal regression analysis was used for WMH and SVD scores in MSS. Results are presented as 
odds ratio (OR) with 95% confidence interval (CI). Predictors were converted to z-scores, such that the resulting 
ORs reflect the odds of having higher pathology ratings for each standard unit increase in the predictor variable. 
Regression analyses were performed with SPSS statistics version 22 (IBM Corp., Armonk, NY).
Data Availability
The datasets generated during and/or analysed during the current study are available from the corresponding 
author on reasonable request.
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